ATH 0.00% 0.5¢ alterity therapeutics limited

Pivalde-- I share your concerns on shareholder non communication...

  1. 382 Posts.
    lightbulb Created with Sketch. 19
    Pivalde-- I share your concerns on shareholder non communication by ATH.

    This paper was partly funded by ATH who would also have had input into the scope of the investigations.
    It was received for review on Dec 2021 and published July.
    As the sponsor and the major funder the company almost certainly had knowledge of the contents of the paper prior to publication.
    It is proper to not acknowledge a paper prior to peer review and publication, but is it proper to not communicate the findings, good or bad, to the shareholders whose capital made it possible?
 
watchlist Created with Sketch. Add ATH (ASX) to my watchlist
(20min delay)
Last
0.5¢
Change
0.000(0.00%)
Mkt cap ! $26.22M
Open High Low Value Volume
0.5¢ 0.5¢ 0.5¢ $18 3.595K

Buyers (Bids)

No. Vol. Price($)
44 40118894 0.5¢
 

Sellers (Offers)

Price($) Vol. No.
0.6¢ 17805079 20
View Market Depth
Last trade - 10.00am 24/05/2024 (20 minute delay) ?
Last
0.5¢
  Change
0.000 ( 0.00 %)
Open High Low Volume
0.5¢ 0.5¢ 0.5¢ 4354767
Last updated 10.19am 24/05/2024 ?
ATH (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.